[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Flu Vaccination Market Growth 2023-2029

January 2023 | 106 pages | ID: GA1DD63C48C1EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.

LPI (LP Information)' newest research report, the “Flu Vaccination Industry Forecast” looks at past sales and reviews total world Flu Vaccination sales in 2022, providing a comprehensive analysis by region and market sector of projected Flu Vaccination sales for 2023 through 2029. With Flu Vaccination sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Flu Vaccination industry.

This Insight Report provides a comprehensive analysis of the global Flu Vaccination landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Flu Vaccination portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Flu Vaccination market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Flu Vaccination and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Flu Vaccination.

The global Flu Vaccination market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Flu Vaccination is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Flu Vaccination is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Flu Vaccination is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Flu Vaccination players cover Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac and BCHT, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Flu Vaccination market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
  • Trivalent Influenza Vaccine
  • Quadrivalent Influenza Vaccine
Segmentation by application
  • 6 Months to 3 Years
  • Above 3 Years
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Sanofi
  • CSL
  • GSK
  • Viatris
  • AstraZeneca
  • Hualan Bio
  • Changchun Institute of Biological
  • Sinovac
  • BCHT
  • Jiangsu GDK
  • KM Biologics
Key Questions Addressed in this Report

What is the 10-year outlook for the global Flu Vaccination market?

What factors are driving Flu Vaccination market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Flu Vaccination market opportunities vary by end market size?

How does Flu Vaccination break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Flu Vaccination Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Flu Vaccination by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Flu Vaccination by Country/Region, 2018, 2022 & 2029
2.2 Flu Vaccination Segment by Type
  2.2.1 Trivalent Influenza Vaccine
  2.2.2 Quadrivalent Influenza Vaccine
2.3 Flu Vaccination Sales by Type
  2.3.1 Global Flu Vaccination Sales Market Share by Type (2018-2023)
  2.3.2 Global Flu Vaccination Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Flu Vaccination Sale Price by Type (2018-2023)
2.4 Flu Vaccination Segment by Application
  2.4.1 6 Months to 3 Years
  2.4.2 Above 3 Years
2.5 Flu Vaccination Sales by Application
  2.5.1 Global Flu Vaccination Sale Market Share by Application (2018-2023)
  2.5.2 Global Flu Vaccination Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Flu Vaccination Sale Price by Application (2018-2023)

3 GLOBAL FLU VACCINATION BY COMPANY

3.1 Global Flu Vaccination Breakdown Data by Company
  3.1.1 Global Flu Vaccination Annual Sales by Company (2018-2023)
  3.1.2 Global Flu Vaccination Sales Market Share by Company (2018-2023)
3.2 Global Flu Vaccination Annual Revenue by Company (2018-2023)
  3.2.1 Global Flu Vaccination Revenue by Company (2018-2023)
  3.2.2 Global Flu Vaccination Revenue Market Share by Company (2018-2023)
3.3 Global Flu Vaccination Sale Price by Company
3.4 Key Manufacturers Flu Vaccination Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Flu Vaccination Product Location Distribution
  3.4.2 Players Flu Vaccination Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR FLU VACCINATION BY GEOGRAPHIC REGION

4.1 World Historic Flu Vaccination Market Size by Geographic Region (2018-2023)
  4.1.1 Global Flu Vaccination Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Flu Vaccination Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Flu Vaccination Market Size by Country/Region (2018-2023)
  4.2.1 Global Flu Vaccination Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Flu Vaccination Annual Revenue by Country/Region (2018-2023)
4.3 Americas Flu Vaccination Sales Growth
4.4 APAC Flu Vaccination Sales Growth
4.5 Europe Flu Vaccination Sales Growth
4.6 Middle East & Africa Flu Vaccination Sales Growth

5 AMERICAS

5.1 Americas Flu Vaccination Sales by Country
  5.1.1 Americas Flu Vaccination Sales by Country (2018-2023)
  5.1.2 Americas Flu Vaccination Revenue by Country (2018-2023)
5.2 Americas Flu Vaccination Sales by Type
5.3 Americas Flu Vaccination Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Flu Vaccination Sales by Region
  6.1.1 APAC Flu Vaccination Sales by Region (2018-2023)
  6.1.2 APAC Flu Vaccination Revenue by Region (2018-2023)
6.2 APAC Flu Vaccination Sales by Type
6.3 APAC Flu Vaccination Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Flu Vaccination by Country
  7.1.1 Europe Flu Vaccination Sales by Country (2018-2023)
  7.1.2 Europe Flu Vaccination Revenue by Country (2018-2023)
7.2 Europe Flu Vaccination Sales by Type
7.3 Europe Flu Vaccination Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Flu Vaccination by Country
  8.1.1 Middle East & Africa Flu Vaccination Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Flu Vaccination Revenue by Country (2018-2023)
8.2 Middle East & Africa Flu Vaccination Sales by Type
8.3 Middle East & Africa Flu Vaccination Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Flu Vaccination
10.3 Manufacturing Process Analysis of Flu Vaccination
10.4 Industry Chain Structure of Flu Vaccination

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Flu Vaccination Distributors
11.3 Flu Vaccination Customer

12 WORLD FORECAST REVIEW FOR FLU VACCINATION BY GEOGRAPHIC REGION

12.1 Global Flu Vaccination Market Size Forecast by Region
  12.1.1 Global Flu Vaccination Forecast by Region (2024-2029)
  12.1.2 Global Flu Vaccination Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Flu Vaccination Forecast by Type
12.7 Global Flu Vaccination Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Sanofi
  13.1.1 Sanofi Company Information
  13.1.2 Sanofi Flu Vaccination Product Portfolios and Specifications
  13.1.3 Sanofi Flu Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Sanofi Main Business Overview
  13.1.5 Sanofi Latest Developments
13.2 CSL
  13.2.1 CSL Company Information
  13.2.2 CSL Flu Vaccination Product Portfolios and Specifications
  13.2.3 CSL Flu Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 CSL Main Business Overview
  13.2.5 CSL Latest Developments
13.3 GSK
  13.3.1 GSK Company Information
  13.3.2 GSK Flu Vaccination Product Portfolios and Specifications
  13.3.3 GSK Flu Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 GSK Main Business Overview
  13.3.5 GSK Latest Developments
13.4 Viatris
  13.4.1 Viatris Company Information
  13.4.2 Viatris Flu Vaccination Product Portfolios and Specifications
  13.4.3 Viatris Flu Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 Viatris Main Business Overview
  13.4.5 Viatris Latest Developments
13.5 AstraZeneca
  13.5.1 AstraZeneca Company Information
  13.5.2 AstraZeneca Flu Vaccination Product Portfolios and Specifications
  13.5.3 AstraZeneca Flu Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
  13.5.4 AstraZeneca Main Business Overview
  13.5.5 AstraZeneca Latest Developments
13.6 Hualan Bio
  13.6.1 Hualan Bio Company Information
  13.6.2 Hualan Bio Flu Vaccination Product Portfolios and Specifications
  13.6.3 Hualan Bio Flu Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
  13.6.4 Hualan Bio Main Business Overview
  13.6.5 Hualan Bio Latest Developments
13.7 Changchun Institute of Biological
  13.7.1 Changchun Institute of Biological Company Information
  13.7.2 Changchun Institute of Biological Flu Vaccination Product Portfolios and Specifications
  13.7.3 Changchun Institute of Biological Flu Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
  13.7.4 Changchun Institute of Biological Main Business Overview
  13.7.5 Changchun Institute of Biological Latest Developments
13.8 Sinovac
  13.8.1 Sinovac Company Information
  13.8.2 Sinovac Flu Vaccination Product Portfolios and Specifications
  13.8.3 Sinovac Flu Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
  13.8.4 Sinovac Main Business Overview
  13.8.5 Sinovac Latest Developments
13.9 BCHT
  13.9.1 BCHT Company Information
  13.9.2 BCHT Flu Vaccination Product Portfolios and Specifications
  13.9.3 BCHT Flu Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
  13.9.4 BCHT Main Business Overview
  13.9.5 BCHT Latest Developments
13.10 Jiangsu GDK
  13.10.1 Jiangsu GDK Company Information
  13.10.2 Jiangsu GDK Flu Vaccination Product Portfolios and Specifications
  13.10.3 Jiangsu GDK Flu Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
  13.10.4 Jiangsu GDK Main Business Overview
  13.10.5 Jiangsu GDK Latest Developments
13.11 KM Biologics
  13.11.1 KM Biologics Company Information
  13.11.2 KM Biologics Flu Vaccination Product Portfolios and Specifications
  13.11.3 KM Biologics Flu Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
  13.11.4 KM Biologics Main Business Overview
  13.11.5 KM Biologics Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Flu Vaccination Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Flu Vaccination Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Trivalent Influenza Vaccine
Table 4. Major Players of Quadrivalent Influenza Vaccine
Table 5. Global Flu Vaccination Sales by Type (2018-2023) & (Units)
Table 6. Global Flu Vaccination Sales Market Share by Type (2018-2023)
Table 7. Global Flu Vaccination Revenue by Type (2018-2023) & ($ million)
Table 8. Global Flu Vaccination Revenue Market Share by Type (2018-2023)
Table 9. Global Flu Vaccination Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Flu Vaccination Sales by Application (2018-2023) & (Units)
Table 11. Global Flu Vaccination Sales Market Share by Application (2018-2023)
Table 12. Global Flu Vaccination Revenue by Application (2018-2023)
Table 13. Global Flu Vaccination Revenue Market Share by Application (2018-2023)
Table 14. Global Flu Vaccination Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Flu Vaccination Sales by Company (2018-2023) & (Units)
Table 16. Global Flu Vaccination Sales Market Share by Company (2018-2023)
Table 17. Global Flu Vaccination Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Flu Vaccination Revenue Market Share by Company (2018-2023)
Table 19. Global Flu Vaccination Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Flu Vaccination Producing Area Distribution and Sales Area
Table 21. Players Flu Vaccination Products Offered
Table 22. Flu Vaccination Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Flu Vaccination Sales by Geographic Region (2018-2023) & (Units)
Table 26. Global Flu Vaccination Sales Market Share Geographic Region (2018-2023)
Table 27. Global Flu Vaccination Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Flu Vaccination Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Flu Vaccination Sales by Country/Region (2018-2023) & (Units)
Table 30. Global Flu Vaccination Sales Market Share by Country/Region (2018-2023)
Table 31. Global Flu Vaccination Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Flu Vaccination Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Flu Vaccination Sales by Country (2018-2023) & (Units)
Table 34. Americas Flu Vaccination Sales Market Share by Country (2018-2023)
Table 35. Americas Flu Vaccination Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Flu Vaccination Revenue Market Share by Country (2018-2023)
Table 37. Americas Flu Vaccination Sales by Type (2018-2023) & (Units)
Table 38. Americas Flu Vaccination Sales by Application (2018-2023) & (Units)
Table 39. APAC Flu Vaccination Sales by Region (2018-2023) & (Units)
Table 40. APAC Flu Vaccination Sales Market Share by Region (2018-2023)
Table 41. APAC Flu Vaccination Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Flu Vaccination Revenue Market Share by Region (2018-2023)
Table 43. APAC Flu Vaccination Sales by Type (2018-2023) & (Units)
Table 44. APAC Flu Vaccination Sales by Application (2018-2023) & (Units)
Table 45. Europe Flu Vaccination Sales by Country (2018-2023) & (Units)
Table 46. Europe Flu Vaccination Sales Market Share by Country (2018-2023)
Table 47. Europe Flu Vaccination Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Flu Vaccination Revenue Market Share by Country (2018-2023)
Table 49. Europe Flu Vaccination Sales by Type (2018-2023) & (Units)
Table 50. Europe Flu Vaccination Sales by Application (2018-2023) & (Units)
Table 51. Middle East & Africa Flu Vaccination Sales by Country (2018-2023) & (Units)
Table 52. Middle East & Africa Flu Vaccination Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Flu Vaccination Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Flu Vaccination Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Flu Vaccination Sales by Type (2018-2023) & (Units)
Table 56. Middle East & Africa Flu Vaccination Sales by Application (2018-2023) & (Units)
Table 57. Key Market Drivers & Growth Opportunities of Flu Vaccination
Table 58. Key Market Challenges & Risks of Flu Vaccination
Table 59. Key Industry Trends of Flu Vaccination
Table 60. Flu Vaccination Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Flu Vaccination Distributors List
Table 63. Flu Vaccination Customer List
Table 64. Global Flu Vaccination Sales Forecast by Region (2024-2029) & (Units)
Table 65. Global Flu Vaccination Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Flu Vaccination Sales Forecast by Country (2024-2029) & (Units)
Table 67. Americas Flu Vaccination Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Flu Vaccination Sales Forecast by Region (2024-2029) & (Units)
Table 69. APAC Flu Vaccination Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Flu Vaccination Sales Forecast by Country (2024-2029) & (Units)
Table 71. Europe Flu Vaccination Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Flu Vaccination Sales Forecast by Country (2024-2029) & (Units)
Table 73. Middle East & Africa Flu Vaccination Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Flu Vaccination Sales Forecast by Type (2024-2029) & (Units)
Table 75. Global Flu Vaccination Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Flu Vaccination Sales Forecast by Application (2024-2029) & (Units)
Table 77. Global Flu Vaccination Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Sanofi Basic Information, Flu Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 79. Sanofi Flu Vaccination Product Portfolios and Specifications
Table 80. Sanofi Flu Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Sanofi Main Business
Table 82. Sanofi Latest Developments
Table 83. CSL Basic Information, Flu Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 84. CSL Flu Vaccination Product Portfolios and Specifications
Table 85. CSL Flu Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. CSL Main Business
Table 87. CSL Latest Developments
Table 88. GSK Basic Information, Flu Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 89. GSK Flu Vaccination Product Portfolios and Specifications
Table 90. GSK Flu Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. GSK Main Business
Table 92. GSK Latest Developments
Table 93. Viatris Basic Information, Flu Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 94. Viatris Flu Vaccination Product Portfolios and Specifications
Table 95. Viatris Flu Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Viatris Main Business
Table 97. Viatris Latest Developments
Table 98. AstraZeneca Basic Information, Flu Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 99. AstraZeneca Flu Vaccination Product Portfolios and Specifications
Table 100. AstraZeneca Flu Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. AstraZeneca Main Business
Table 102. AstraZeneca Latest Developments
Table 103. Hualan Bio Basic Information, Flu Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 104. Hualan Bio Flu Vaccination Product Portfolios and Specifications
Table 105. Hualan Bio Flu Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Hualan Bio Main Business
Table 107. Hualan Bio Latest Developments
Table 108. Changchun Institute of Biological Basic Information, Flu Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 109. Changchun Institute of Biological Flu Vaccination Product Portfolios and Specifications
Table 110. Changchun Institute of Biological Flu Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Changchun Institute of Biological Main Business
Table 112. Changchun Institute of Biological Latest Developments
Table 113. Sinovac Basic Information, Flu Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 114. Sinovac Flu Vaccination Product Portfolios and Specifications
Table 115. Sinovac Flu Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Sinovac Main Business
Table 117. Sinovac Latest Developments
Table 118. BCHT Basic Information, Flu Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 119. BCHT Flu Vaccination Product Portfolios and Specifications
Table 120. BCHT Flu Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. BCHT Main Business
Table 122. BCHT Latest Developments
Table 123. Jiangsu GDK Basic Information, Flu Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 124. Jiangsu GDK Flu Vaccination Product Portfolios and Specifications
Table 125. Jiangsu GDK Flu Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Jiangsu GDK Main Business
Table 127. Jiangsu GDK Latest Developments
Table 128. KM Biologics Basic Information, Flu Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 129. KM Biologics Flu Vaccination Product Portfolios and Specifications
Table 130. KM Biologics Flu Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. KM Biologics Main Business
Table 132. KM Biologics Latest Developments

LIST OF FIGURES

Figure 1. Picture of Flu Vaccination
Figure 2. Flu Vaccination Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Flu Vaccination Sales Growth Rate 2018-2029 (Units)
Figure 7. Global Flu Vaccination Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Flu Vaccination Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Trivalent Influenza Vaccine
Figure 10. Product Picture of Quadrivalent Influenza Vaccine
Figure 11. Global Flu Vaccination Sales Market Share by Type in 2022
Figure 12. Global Flu Vaccination Revenue Market Share by Type (2018-2023)
Figure 13. Flu Vaccination Consumed in 6 Months to 3 Years
Figure 14. Global Flu Vaccination Market: 6 Months to 3 Years (2018-2023) & (Units)
Figure 15. Flu Vaccination Consumed in Above 3 Years
Figure 16. Global Flu Vaccination Market: Above 3 Years (2018-2023) & (Units)
Figure 17. Global Flu Vaccination Sales Market Share by Application (2022)
Figure 18. Global Flu Vaccination Revenue Market Share by Application in 2022
Figure 19. Flu Vaccination Sales Market by Company in 2022 (Units)
Figure 20. Global Flu Vaccination Sales Market Share by Company in 2022
Figure 21. Flu Vaccination Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Flu Vaccination Revenue Market Share by Company in 2022
Figure 23. Global Flu Vaccination Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Flu Vaccination Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Flu Vaccination Sales 2018-2023 (Units)
Figure 26. Americas Flu Vaccination Revenue 2018-2023 ($ Millions)
Figure 27. APAC Flu Vaccination Sales 2018-2023 (Units)
Figure 28. APAC Flu Vaccination Revenue 2018-2023 ($ Millions)
Figure 29. Europe Flu Vaccination Sales 2018-2023 (Units)
Figure 30. Europe Flu Vaccination Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Flu Vaccination Sales 2018-2023 (Units)
Figure 32. Middle East & Africa Flu Vaccination Revenue 2018-2023 ($ Millions)
Figure 33. Americas Flu Vaccination Sales Market Share by Country in 2022
Figure 34. Americas Flu Vaccination Revenue Market Share by Country in 2022
Figure 35. Americas Flu Vaccination Sales Market Share by Type (2018-2023)
Figure 36. Americas Flu Vaccination Sales Market Share by Application (2018-2023)
Figure 37. United States Flu Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Flu Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Flu Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Flu Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Flu Vaccination Sales Market Share by Region in 2022
Figure 42. APAC Flu Vaccination Revenue Market Share by Regions in 2022
Figure 43. APAC Flu Vaccination Sales Market Share by Type (2018-2023)
Figure 44. APAC Flu Vaccination Sales Market Share by Application (2018-2023)
Figure 45. China Flu Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Flu Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Flu Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Flu Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Flu Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Flu Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Flu Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Flu Vaccination Sales Market Share by Country in 2022
Figure 53. Europe Flu Vaccination Revenue Market Share by Country in 2022
Figure 54. Europe Flu Vaccination Sales Market Share by Type (2018-2023)
Figure 55. Europe Flu Vaccination Sales Market Share by Application (2018-2023)
Figure 56. Germany Flu Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Flu Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Flu Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Flu Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Flu Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Flu Vaccination Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Flu Vaccination Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Flu Vaccination Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Flu Vaccination Sales Market Share by Application (2018-2023)
Figure 65. Egypt Flu Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Flu Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Flu Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Flu Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Flu Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Flu Vaccination in 2022
Figure 71. Manufacturing Process Analysis of Flu Vaccination
Figure 72. Industry Chain Structure of Flu Vaccination
Figure 73. Channels of Distribution
Figure 74. Global Flu Vaccination Sales Market Forecast by Region (2024-2029)
Figure 75. Global Flu Vaccination Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Flu Vaccination Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Flu Vaccination Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Flu Vaccination Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Flu Vaccination Revenue Market Share Forecast by Application (2024-2029)


More Publications